Skip to search formSkip to main contentSkip to account menu

Therapy-Related Myelodysplastic Syndrome

Known as: Therapy Related Myelodysplastic Syndrome, Therapy-Related MDS, t-MDS 
A myelodysplastic syndrome caused by chemotherapy and/or radiotherapy.
National Institutes of Health

Related topics

Related topics

8 relations
Bone MarrowBone marrow stem cellHematopoietic and Lymphoid CellHematopoietic and Lymphoid Tissue

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Graft-versus-leukemia effect with a WT1-specific T-cell response induced by azacitidine and donor lymphocyte infusions after allogeneic hematopoietic stem cell transplantation.
2005
2005
Treatment-related myelodysplastic syndrome/acute myeloid leukemia in survivors of childhood cancer--an update.
Treatment-related myelodysplastic syndrome/acute myeloid leukemia (t-MDS/t-AML) is a devastating complication of treatment for… 
2003
2003
Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones
Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex… 
2003
2003
Rearrangement of the MOZ gene in pediatric therapy‐related myelodysplastic syndrome with a novel chromosomal translocation t(2;8)(p23;p11)
In this study, we examined a pediatric case of therapy‐related myelodysplastic syndrome (tMDS). The symptoms developed 17 months… 
2003
2003
A novel fusion variant of the MORF and CBP genes detected in therapy‐related myelodysplastic syndrome with t(10;16)(q22;p13)
Summary. We report a case of therapy‐related myelodysplastic syndrome (t‐MDS) with t(10;16)(q22;p13), in which novel fusion… 
Review
1994
Review
1994
Involvement of 11p15 and 3q21q26 in therapy-related myeloid leukemia (t-ML) in children. Case reports and review of the literature.
Review
1993
Review
1993
Myelodysplastic syndrome after cisplatin therapy
Therapy‐related myelodysplastic syndrome (tMDS) and acute nonlymphocytic leukemia (tANLL) are known late complications of… 
1993
1993
Therapy-related myelodysplastic syndromes: FAB classification, bone marrow histology, and immunohistology in the prognostic assessment.
In this study we describe the morphologic and immunohistochemical evaluation of bone marrow biopsies from 14 patients with… 
1990
1990
Cytogenetic study in therapy-related myelodysplastic syndromes (t-MDS) and acute non-lymphocytic leukaemia (t-ANLL).
A cytogenetic study was performed in 27 patients suspected of t-MDS or t-ANLL. In 12 patients the diagnosis of t-MDS or t-ANLL… 
Highly Cited
1989
Highly Cited
1989
Mechanisms of ras mutation in myelodysplastic syndrome.
Using synthetic oligonucleotide hybridization, we have found a ras mutation in 11 of 27 patients (41%) with primary or non… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)